TREM2 analysis and increased risk of Alzheimer's disease

Neurobiology of Aging

Volumn 36, Issue 1, 2015, Pages 546.e9-546.e13

  Finelli, Deana ^a   Rollinson, Sara ^a   Harris, Jenny ^a   Jones, Matthew ^a,b   Richardson, Anna ^a,b   Gerhard, Alex ^a,b   Snowden, Julie ^a,b   Mann, David ^a   Pickering Brown, Stuart ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Risk factor; TREM2

Indexed keywords

MEMBRANE RECEPTOR; TREM2 PROTEIN; UNCLASSIFIED DRUG; ARGININE; CYTOKINE; HISTIDINE; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TREM2 GENE; UNITED KINGDOM; VERY ELDERLY; CHEMISTRY; COHORT ANALYSIS; GENETIC VARIATION; GENETICS; GREAT BRITAIN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROGLIA; PHAGOCYTOSIS; PHYSIOLOGY; RISK;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARGININE; COHORT STUDIES; CYTOKINES; FEMALE; GENETIC VARIATION; GREAT BRITAIN; HISTIDINE; HUMANS; IMMUNITY, INNATE; MALE; MEMBRANE GLYCOPROTEINS; MICROGLIA; MIDDLE AGED; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC; RISK;

EID: 84920425940     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.08.001     Document Type: Article

References (34)

1. Benitez B.A., Cooper B., Pastor P., Jin S.-C., Lorenzo E., Cervantes S., Cruchaga C. TREM2 is associated with the risk of Alzheimer's disease in Spanish population. Neurobiol. Aging 2013, 34:1711.
2. Bertram L., Parrado A.R., Tanzi R.E. TREM2 and neurodegenerative disease. New Engl. J. Med. 2013, 369:1565.
3. Bianchin M.M., Capella H.M., Chaves D.L., Steindel M., Grisard E.C., Ganev G.G., da Silva J.P., Neto Evaldo S., Poffo M.A., Walz R., Carlotti C.G., Sakamoto A.C. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy-PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell Mol. Neurobiol. 2004, 24:1-24.
4. Bouchon A., Hernández-Munain C., Cella M., Colonna M. ADAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J.Exp. Med. 2001, 194:1111-1122.
5. Cella M., Buonsanti C., Strader C., Kondo T., Salmaggi A., Colonna M. Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J.Exp. Med. 2003, 198:645-651.
6. Chouery E., Delague V., Bergougnoux A., Koussa S., Serre J.L., Mégarbané A. Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Hum. Mutat. 2008, 29:E194-E204.
7. Colonna M. TREMs in the immune system and beyond. Nat. Rev. Immunol. 2003, 3:445-453.
8. Escott-Price V., Bellenguez C., Wang L.S., Choi S.H., Harold D., Jones L., Holmans P., Gerrish A., Vedernikov A., Richards A., DeStefano A.L., Lambert J.C., Ibrahim-Verbaas C.A., Naj A.C., Sims R., Jun G., Bis J.C., Beecham G.W., Grenier-Boley B., Russo G., Thornton-Wells T.A., Denning N., Smith A.V., Chouraki V., Thomas C., Ikram M.A., Zelenika D., Vardarajan B.N., Kamatani Y., Lin C.F., Schmidt H., Kunkle B., Dunstan M.L., Vronskaya M., Johnson A.D., Ruiz A., Bihoreau M.T., Reitz C., Pasquier F., Hollingworth P., Hanon O., Fitzpatrick A.L., Buxbaum J.D., Campion D., Crane P.K., Baldwin C., Becker T., Gudnason V., Cruchaga C., Craig D., Amin N., Berr C., Lopez O.L., De Jager P.L., Deramecourt V., Johnston J.A., Evans D., Lovestone S., Letenneur L., Hernandez I., Rubinsztein D.C., Eiriksdottir G., Sleegers K., Goate A.M., Fievet N., Huentelman M.J., Gill M., Brown K., Kamboh M.I., Keller L., Barberger-Gateau P., McGuinness B., Larson E.B., Myers A.J., Dufouil C., Todd S., Wallon D., Love S., Rogaeva E., Gallacher J., George-Hyslop P.S., Clarimon J., Lleo A., Bayer A., Tsuang D.W., Yu L., Tsolaki M., Bossu P., Spalletta G., Proitsi P., Collinge J., Sorbi S., Garcia F.S., Fox N.C., Hardy J., Naranjo M.C., Bosco P., Clarke R., Brayne C., Galimberti D., Scarpini E., Bonuccelli U., Mancuso M., Siciliano G., Moebus S., Mecocci P., Zompo M.D., Maier W., Hampel H., Pilotto A., Frank-Garcia A., Panza F., Solfrizzi V., Caffarra P., Nacmias B., Perry W., Mayhaus M., Lannfelt L., Hakonarson H., Pichler S., Carrasquillo M.M., Ingelsson M., Beekly D., Alvarez V., Zou F., Valladares O., Younkin S.G., Coto E., Hamilton-Nelson K.L., Gu W., Razquin C., Pastor P., Mateo I., Owen M.J., Faber K.M., Jonsson P.V., Combarros O., O'Donovan M.C., Cantwell L.B., Soininen H., Blacker D., Mead S., Mosley T.H., Bennett D.A., Harris T.B., Fratiglioni L., Holmes C., de Bruijn R.F., Passmore P., Montine T.J., Bettens K., Rotter J.I., Brice A., Morgan K., Foroud T.M., Kukull W.A., Hannequin D., Powell J.F., Nalls M.A., Ritchie K., Lunetta K.L., Kauwe J.S., Boerwinkle E., Riemenschneider M., Boada M., Hiltunen M., Martin E.R., Schmidt R., Rujescu D., Dartigues J.F., Mayeux R., Tzourio C., Hofman A., Nothen M.M., Graff C., Psaty B.M., Haines J.L., Lathrop M., Pericak-Vance M.A., Launer L.J., Van Broeckhoven C., Farrer L.A., van Duijn C.M., Ramirez A., Seshadri S., Schellenberg G.D., Amouyel P., Williams J. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. PLoS One 2014, 9:e94661.
9. Frank S., Burbach G.J., Bonin M., Walter M., Streit W., Bechmann I., Deller T. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 2008, 56:1438-1447.
10. Giraldo M., Lopera F., Siniard A.L., Corneveaux J.J., Schrauwen I., Carvajal J., Muñoz C., Ramirez-Restrepo M., Gaiteri C., Myers A.J., Caselli R.J., Kosik K.S., Reiman E.M., Huentelman M.J. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol. Aging 2013, 34:2077.
11. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S. TREM2 variants in Alzheimer's disease. N.Engl. J. Med. 2013, 368:117-127.
12. Guerreiro R.J., Lohmann E., Brás J.M., Gibbs J.R., Rohrer J.D., Gurunlian N., Dursun B., Bilgic B., Hanagasi H., Gurvit H., Emre M., Singleton A., Hardy J. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement TREM2 mutations and frontotemporal dementia. JAMA Neurol. 2013, 70:78-84.
13. Hamerman J.A., Jarjoura J.R., Humphrey M.B., Nakamura M.C., Seaman W.E., Lanier L.L. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J.Immunol. 2006, 177:2051-2055.
14. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
15. Hickman S.E., Allison E.K., El Khoury J. Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice. J.Neurosci. 2008, 28:8354-8360.
16. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.-C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 2011, 43:429-435.
17. Ito H., Hamerman J.A. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur. J. Immunol. 2012, 42:176-185.
18. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J. Variant of TREM2 associated with the risk of Alzheimer's disease. N.Engl. J. Med. 2013, 368:107-116.
19. Kaifu T., Nakahara J., Inui M., Mishima K., Momiyama T., Kaji M., Sugahara A., Koito H., Ujike-Asai A., Nakamura A., Kanazawa K., Tan-Takeuchi K., Iwasaki K., Yokoyama W.M., Kudo A., Fujiwara M., Asou H., Takai T. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J.Clin. Invest. 2003, 111:323-332.
20. Kidd M. Alzheimer's disease-an electron microscopical study. Brain 1964, 87:307-320.
21. Lambert J.-C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41:1094-1099.
22. Lambert J.C., Ibrahim-Verbaas C.A., Harold D., Naj A.C., Sims R., Bellenguez C., DeStafano A.L., Bis J.C., Beecham G.W., Grenier-Boley B., Russo G., Thorton-Wells T.A., Jones N., Smith A.V., Chouraki V., Thomas C., Ikram M.A., Zelenika D., Vardarajan B.N., Kamatani Y., Lin C.F., Gerrish A., Schmidt H., Kunkle B., Dunstan M.L., Ruiz A., Bihoreau M.T., Choi S.H., Reitz C., Pasquier F., Cruchaga C., Craig D., Amin N., Berr C., Lopez O.L., De Jager P.L., Deramecourt V., Johnston J.A., Evans D., Lovestone S., Letenneur L., Moron F.J., Rubinsztein D.C., Eiriksdottir G., Sleegers K., Goate A.M., Fievet N., Huentelman M.W., Gill M., Brown K., Kamboh M.I., Keller L., Barberger-Gateau P., McGuiness B., Larson E.B., Green R., Myers A.J., Dufouil C., Todd S., Wallon D., Love S., Rogaeva E., Gallacher J., St George-Hyslop P., Clarimon J., Lleo A., Bayer A., Tsuang D.W., Yu L., Tsolaki M., Bossu P., Spalletta G., Proitsi P., Collinge J., Sorbi S., Sanchez-Garcia F., Fox N.C., Hardy J., Deniz Naranjo M.C., Bosco P., Clarke R., Brayne C., Galimberti D., Mancuso M., Matthews F., Moebus S., Mecocci P., Del Zompo M., Maier W., Hampel H., Pilotto A., Bullido M., Panza F., Caffarra P., Nacmias B., Gilbert J.R., Mayhaus M., Lannefelt L., Hakonarson H., Pichler S., Carrasquillo M.M., Ingelsson M., Beekly D., Alvarez V., Zou F., Valladares O., Younkin S.G., Coto E., Hamilton-Nelson K.L., Gu W., Razquin C., Pastor P., Mateo I., Owen M.J., Faber K.M., Jonsson P.V., Combarros O., O'Donovan M.C., Cantwell L.B., Soininen H., Blacker D., Mead S., Mosley T.H., Bennett D.A., Harris T.B., Fratiglioni L., Holmes C., de Bruijn R.F., Passmore P., Montine T.J., Bettens K., Rotter J.I., Brice A., Morgan K., Foroud T.M., Kukull W.A., Hannequin D., Powell J.F., Nalls M.A., Ritchie K., Lunetta K.L., Kauwe J.S., Boerwinkle E., Riemenschneider M., Boada M., Hiltuenen M., Martin E.R., Schmidt R., Rujescu D., Wang L.S., Dartigues J.F., Mayeux R., Tzourio C., Hofman A., Nothen M.M., Graff C., Psaty B.M., Jones L., Haines J.L., Holmans P.A., Lathrop M., Pericak-Vance M.A., Launer L.J., Farrer L.A., van Duijn C.M., Van Broeckhoven C., Moskvina V., Seshadri S., Williams J., Schellenberg G.D., Amouyel P. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 2013, 45:1452-1458.
23. Melchior B., Garcia A.E., Hsiung B., Lo K.M., Doose J.M., Stalder A., Staufenbiel M., Neumann H., Carson M. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro. 2010, 2:e00037.
24. Montalbetti L., Ratti M., Greco B., Aprile C., Moglia A., Soragna D. Neuropsychological tests and functional nuclear neuroimaging provide evidence of subclinical impairment in Nasu-Hakola disease heterozygotes. Funct. Neurol. 2005, 20:71-75.
25. Naj A.C., Jun G., Beecham G.W., Wang L.-S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43:436-441.
26. Neumann H., Takahashi K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J.Neuroimmunol. 2007, 184:92-99.
27. Paloneva J., Manninen T., Christman G., Hovanes K., Mandelin J., Adolfsson R., Bianchin M., Bird T., Miranda R., Salmaggi A., Tranebjaerg L., Konttinen Y., Peltonen L. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 2002, 71:656-662.
28. Pottier C., Wallon D., Rousseau S., Rovelet-Lecrux A., Richard A.-C., Rollin-Sillaire A., Frebourg T., Campion D., Hannequin D. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. J.Alzheimers Dis. 2013, 35:45-49.
29. Rayaprolu S., Mullen B., Baker M., Lynch T., Finger E., Seeley W.W., Hatanpaa K.J., Lomen-Hoerth C., Kertesz A., Bigio E.H. TREM2 in neurodegeneration: evidence for association of the p. R47H variant with frontotemporal dementia and Parkinson's disease. Mol. Neurodegener. 2013, 8:19.
30. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carrasquillo M.M., Lambert J.C. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840.
31. Sessa G., Podini P., Mariani M., Meroni A., Spreafico R., Sinigaglia F., Colonna M., Panina P., Meldolesi J. Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia. Eur. J. Neurosci. 2004, 20:2617-2628.
32. Takahashi K., Rochford C.D., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J.Exp. Med. 2005, 201:647-657.
33. Terry R.D. The fine structure of neurofibrillary tangles in Alzheimer's disease. J.Neuropathol. Exp. Neurol. 1963, 22:629-642.
34. Yamamoto M., Kiyota T., Horiba M., Buescher J.L., Walsh S.M., Gendelman H.E., Ikezu T. Interferon-γ and tumor necrosis factor-α regulate amyloid-β plaque deposition and β-secretase expression in Swedish mutant APP transgenic mice. Am. J. Pathol. 2007, 170:680-692.